ORLANDO, Florida — Two lasers developed specifically to target the sebaceous gland were cleared by the US Food and Drug Administration (FDA) for the treatment of acne vulgaris in 2022, but it is unclear whether there are meaningful clinical differences between them. The good news has been the relatively high rates of efficacy reported with ...
.png)
Market Touch Signal · Finland · international digital desk
+358 400 512311
info@market-touch.org
